Katholisches Klinikum Mainz

Mainz 55131

0 studies enrolling now · 6 studies all time

What they study most

Atrial Fibrillation, Breast Neoplasms, Heart Failure, Hypertension, Myocardial Infarction, Peripheral Arterial Disease, Vascular Diseases

Studies at this site

• A Study of the ReCor Medical Paradise System in Clinical Hypertension — Running, not enrolling
• EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction) — Completed
• A Study of Palbociclib (PD-0332991) + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer (PALOMA-2) — Completed
• Shockwave Medical Peripheral Lithoplasty System Study for PAD (Disrupt PAD III) — Completed
• EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved) — Completed
• Study Of The Blood Thinner, Apixaban, For Patients Who Have An Abnormal Heart Rhythm (Atrial Fibrillation) And Expected To Have Treatment To Put Them Back Into A Normal Heart Rhythm (Cardioversion) — Completed